IRONWOOD PHARMACEUTICALS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2015 | $-106.9M | $-111.0M | $4.0M | $25.5M |
| FY2016 | $-25.9M | $-30.1M | $4.2M | $29.2M |
| FY2017 | $-100.8M | $-103.6M | $2.8M | $30.9M |
| FY2018 | $-70.9M | $-71.2M | $351.0K | $40.5M |
| FY2019 | $10.7M | $3.5M | $7.2M | $31.3M |
| FY2020 | $168.8M | $167.0M | $1.8M | $31.2M |
| FY2021 | $261.9M | $261.6M | $265.0K | $22.3M |
| FY2022 | $273.8M | $273.6M | $136.0K | $27.0M |
| FY2023 | $183.4M | $183.2M | $273.0K | $32.0M |
| FY2024 | $103.5M | $103.4M | $142.0K | $29.9M |